Recent news on Carac

AP Pharma Q4 loss doubles  -  Mar 7, 2007
San Jose Business Journal,AP Pharma sold the rights to royalties from Retin-A-Micro and Carac in October 2005. The one time gain of $23.4 million from that sale was recorded in the

AP Pharma Reports Results for the Fourth Quarter and Full Year ...  -  Mar 7, 2007
PharmaLive.com (press release),Carac(R) is a registered trademark owned by sanofi-aventis US LLC. This news release contains "forward-looking statements" as defined by the Private

AP Pharma Posts Wider Loss In Q3 - Update  Nov 7, 2006
...no revenues in the third quarter, which reflected the sale effective October 1, 2005, of rights to receive royalties on sales of Retin-A Micro and Carac. ... -Trading Markets, Saving your SKIN  Jul 31, 2006
...dry spots that wouldn't go away no matter how much lotion he applied were treated by freezing them with liquid nitrogen and a cream called Carac, a product ... -MLive.com

AP Pharma Reports 2006 Second Quarter Results; Phase 3 Clinical ...  Aug 8, 2006
...of the prior year, as effective October 1, 2005, AP Pharma completed the sale of its interest in royalties on sales of Retin-A Micro(R) and Carac(R). The ... -Business Wire

On The Boards  Jun 21, 2006
THE PLAY: Mad Masque Productions presents Cardboard Boxes, by Carac Allison; directed by Dan Ebbs; featuring Shawn Franklin and Kerrie McInroy. ... -London Free Press



AP Pharma Reports 2006 First Quarter Results; Phase 3 Clinical ...  May 10, 2006
During the quarter, the Company completed the sale of its interests in royalties on sales of Retin-A Micro(R) and Carac(R) effective October 1, 2005. ... - PharmaLive.com





AP Pharma Reports 2005 Full Year and Fourth Quarter Results ...  Mar 15, 2006
Received $25 million in January 2006 from the sale of the Company's interest in royalties from Retin-A Micro(R) and Carac(R). -- Nasdaq National Market ... - Business Wire

AP Pharma Completes Financing for up to $30 Million; Sells Royalty ...  Jan 18, 2006
AP Pharma, Inc. (NASDAQ:APPA) today announced that it has sold rights to future royalties on sales of Retin-A Micro(R) and Carac(R) to an affiliate of the Paul ... - Genetic Engineering News

AP Pharma makes $30M royalty sale to prevent delisting  Jan 18, 2006
AP Pharma gets royalties on the sales of Retin-A Micro and Carac through license agreements with Ortho Neutrogena (formerly Ortho Dermatological), a Johnson & ... - Bizjournals.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional